Molly Henderson - 20 Nov 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: CFO and CBO
Signature: /s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Issuer symbol: PHAT
Transactions as of: 20 Nov 2023
Net transactions value: -$15,403
Form type: 4
Filing time: 21 Nov 2023, 16:40:36 UTC
Previous filing: 03 Nov 2023
Next filing: 22 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Sale	$15,403	-2,127	-2%	$7.24	103,061	20 Nov 2023	Direct	F1, F2
holding	PHAT	Common Stock						1,134	20 Nov 2023	By 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $7.24 and $7.2893. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $7.24 and $7.2893. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.